Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update

Go back to Seres Therapeutics Reports First Quarter Financial Results and Provides Clinical Pipeline Progress Update
(NASDAQ: MCRB) Delayed: 5.56 -0.16 (2.8%)
Previous Close $5.72    52 Week High $44.51 
Open $5.68    52 Week Low $8.05 
Day High $5.75    P/E N/A 
Day Low $5.40    EPS $0.00 
Volume 36,654